Antibody-dependent Cytotoxicity

Fc receptors provide the recognition step that connects antibody binding with effector-cell activation. Once antibodies attach to antigens on an infected or abnormal cell, these receptors recognize the antibodies’ Fc regions rather than the target antigen itself. This enables natural killer cells and other cytotoxic effector cells to identify antibody-coated targets and initiate the processes leading to cell elimination.

Recognition through Fc receptors activates the cytotoxic immune cell and promotes degranulation, the release of stored toxic molecules from intracellular granules. Perforin and granzymes are then released toward the bound target. Together, these molecules induce target-cell death, providing the main effector outcome of the antibody-directed response.

Antibodies provide antigen-specific recognition, a function associated with adaptive immunity, while natural killer cells and other effector cells supply the cytotoxic response associated with innate immune activity. Antibody-dependent cytotoxicity therefore links these two arms of immunity: antibody binding determines which cell is targeted, and Fc-receptor-bearing cells execute its destruction.

Vaccine-induced antibodies can be studied for their capacity to direct cytotoxic immune cells against relevant infected or abnormal targets. Such evaluation extends beyond asking whether antibodies recognize an antigen, because it considers whether antibody binding can recruit Fc-receptor-bearing effector cells and produce cytotoxic activity. This helps characterize functional features of vaccine-induced immunity.

The mechanism helps explain how antibodies contribute to defense against pathogens and cells infected by them. It provides a framework for examining the transition from antibody recognition of pathogen-associated targets to effector-cell activation and target-cell death. In infection research, this perspective can clarify how antibody responses may participate in eliminating infected cells.

Therapeutic antibodies can be designed or assessed in relation to their ability to direct cytotoxic immune cells toward selected abnormal cells. Their intended effect depends on antibody binding to the target and subsequent recognition of the Fc region by effector-cell receptors. This makes cytotoxicity a relevant outcome when evaluating targeted antibody-mediated cell killing.